NPRA mandates that all pharmaceutical products must display essential information in writing directly on their packaging. This requirement ensures that critical product details remain visible and accessible throughout every stage of the supply chain, enabling healthcare professionals and regulatory authorities to verify product authenticity and maintain proper handling protocols.

Each sellable unit of pharmaceutical products must carry a unique identifier through serialization technology. This distinctive coding system assigns individual serial numbers to every product unit, creating a digital fingerprint that enables precise tracking, verification, and authentication throughout the entire distribution network from manufacturer to end consumer.

The system requires comprehensive identification and documentation of packaging relationships across all levels. This encompasses the clear mapping of connections between primary packaging (such as blister packs), secondary packaging (boxes), and tertiary packaging (shipping cartons), ensuring complete traceability from the smallest sellable unit to larger distribution containers.

NPRA's pilot project establishes a structured compliance framework that aligns with international pharmaceutical supply chain security standards. The initiative includes systematic oversight mechanisms, regular monitoring protocols, and standardized reporting procedures to ensure pharmaceutical stakeholders maintain adherence to track and trace requirements while supporting broader public health objectives.